Estimating the effect of increasing utilization of living donor liver transplantation using observational data. (26th February 2021)

• Record Type: Journal Article
• Authors: Wanis, Kerollos Nashat; Sarvet, Aaron; Ruffolo, Luis I.; Levstik, Mark A; Tomiyama, Koji; Al‐Judaibi, Bandar M.; Stensrud, Mats J; Hernandez‐Alejandro, Roberto
• Is Part Of: Transplant international. Volume 34:Number 4(2021)
• Page Start: 648
• Page End: 656
• Publication Date: 2021-02-26
• Subjects: causal inference -- epidemiology -- health policy -- organ utilization -- transplantation; Transplantation of organs, tissues, etc -- Periodicals; 617.95405
• DOI: 10.1111/tri.13835
• Languages: English
• ISSNs: 0934-0874

Abstract

Summary: There has been a recent increase in enthusiasm for expansion of living donor liver transplantation (LDLT) programmes. Using all adults initially placed on the waiting list in the United States, we estimated the risk of overall mortality under national strategies which differed in their utilization of LDLT. We used a generalization of inverse probability weighting which can estimate the effect of interventions in the setting of finite resources. From 2005 to 2015, 93 812 eligible individuals were added to the waitlist: 51 322 received deceased donor grafts while 1970 underwent LDLT. Individuals who underwent LDLT had more favourable prognostic factors, including lower mean MELD score at transplant (14.6 vs. 20.5). The 1‐year, 5‐year and 10‐year cumulative incidence of death under the current level of LDLT utilization were 18.0% (95% CI: 17.8, 18.3%), 41.2% (95% CI: 40.8, 41.5%) and 57.4% (95% CI: 56.9, 57.9%) compared to 17.9% (95% CI: 17.7, 18.2%), 40.6% (95% CI: 40.2, 40.9%) and 56.4% (95% CI: 55.8, 56.9%) under a strategy which doubles LDLT utilization. Expansion of LDLT utilization would have a measurable, modest effect on the risk of mortality for the entire cohort of individuals who begin on the transplant waiting list.